Adeoye Y. Olukotun, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 2,850 shares at $20.00 ($57K) on 2024-12-27, disclosed to the SEC on 2024-12-30.
Scheduled sale ($57k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARWR | SELL | 2025-01-27 | $20K | — | Filing → |
| ARWR | SELL | 2023-03-06 | $741K | — | Filing → |
| ARWR | SELL | 2022-01-04 | $508K | — | Filing → |